Survivor, caregiver, or friend? Share your brain tumor story and inspire others.
Sign up for our bi-monthly email to get the latest news on treatments, support, and stories from the brain tumor community.
CHICAGO, Ill. (November 4, 2025) — The American Brain Tumor Association (ABTA) announced the awarding of more than $1.3 million toward new grants in 2025 to advance brain tumor research and treatments. This funding comes at
Grants Support Innovative, High-Risk Research Aimed at Improving Diagnosis and Treatment of CNS Metastases CHICAGO, October 15, 2025 — The Metastatic Brain Tumor Collaborative (MBTC), created by the American Brain Tumor Association (ABTA) announced
Two Multi-Institutional Teams Selected to Improve Diagnosis and Monitoring of Primary Brain Tumors CHICAGO, September 23, 2025 — The Brain Tumor Funders’ Collaborative (BTFC) today announced $1 million in grant
American Brain Tumor Association Names New President & Chief Executive Officer Proven Leader Spearheaded Organization’s Dynamic Development Team, Volunteer Network CHICAGO – (November 18, 2024). The American Brain Tumor Association
Brain Tumor Funders’ Collaborative Announces New Grant Opportunity to Support Studies on Liquid Biopsy in Primary Brain Tumors The Brain Tumor Funders’ Collaborative (BTFC) announced a request for proposals for
American Brain Tumor Association Awards Over $1 Million in New Grants to Advance Brain Cancer Research Chicago, IL (October 17, 2024)— The American Brain Tumor Association (ABTA) is proud to
Meet the ABTA’s newest Board Members, Laura Aguilar, MD, PhD, and Charles (Chad) Schafer, JD.
Chicago, IL (May 6, 2024)—The American Brain Tumor Association (ABTA) announced that President and CEO Ralph A. DeVitto has informed the Board of Directors of his intention to retire from ABTA in January 2025, after leading the organization for nearly seven years.
CHICAGO (May 7, 2024)—Today, the American Brain Tumor Association (ABTA), in partnership with the National Institutes of Health’s National Cancer Institute (NCI) Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT) program and the Central Brain Tumor Registry of the United States (CBTRUS), unveiled a new report shedding light on the prevalence of primary brain and other central nervous system (CNS) tumors among adolescents and young adults (AYAs) between the ages of 15 and 39.
Always free for patients & caregivers
